Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001178913-23-001679
Filing Date
2023-05-03
Accepted
2023-05-03 16:32:03
Documents
62
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zk2329636.htm   iXBRL 10-K/A 1161592
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9288
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 9481
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5575
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5441
11 GRAPHIC image1.jpg GRAPHIC 3875
12 GRAPHIC image2.jpg GRAPHIC 33539
13 GRAPHIC image00005.jpg GRAPHIC 103294
14 GRAPHIC image00007.jpg GRAPHIC 11182
  Complete submission text file 0001178913-23-001679.txt   4992446

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atms-20221231.xsd EX-101.SCH 41413
7 XBRL CALCULATION FILE atms-20221231_cal.xml EX-101.CAL 34298
8 XBRL DEFINITION FILE atms-20221231_def.xml EX-101.DEF 103645
9 XBRL LABEL FILE atms-20221231_lab.xml EX-101.LAB 512691
10 XBRL PRESENTATION FILE atms-20221231_pre.xml EX-101.PRE 202902
56 EXTRACTED XBRL INSTANCE DOCUMENT zk2329636_htm.xml XML 568007
Mailing Address 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507
Business Address 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-24431 | Film No.: 23884613
SIC: 2890 Miscellaneous Chemical Products